(Q38485998)

English

Patients with unresectable hepatocellular carcinoma beyond Milan criteria: should we perform transarterial chemoembolization or liver transplantation?

scientific article published on April 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Patients with unresectable hepatocellular carcinoma beyond Milan criteria: should we perform transarterial chemoembolization or liver transplantation? (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

author name string

J M Kim

1

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

C H D Kwon

2

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

J-W Joh

3

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

S J Kim

4

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

M Shin

5

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

E Y Kim

6

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

J I Moon

7

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

G O Jung

8

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

G-S Choi

9

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

S-K Lee

10

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

language of work or name

0 references

publication date

1 April 2010

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Transplantation Proceedings

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

42

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

821-824

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.02.027

7 January 2021

Liver metastases of neuroendocrine carcinomas: interventional treatment via transarterial embolization, chemoembolization and thermal ablation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.02.027

7 January 2021

Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.02.027

7 January 2021

Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.02.027

7 January 2021

Expanded criteria for liver transplantation in patients with cirrhosis and hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.02.027

7 January 2021

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.02.027

7 January 2021

Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.02.027

7 January 2021

Long-term results with multimodal adjuvant therapy and liver transplantation for the treatment of hepatocellular carcinomas larger than 5 centimeters

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.02.027

7 January 2021

Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.02.027

7 January 2021

Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization: a multicenter randomized trial. Groupe CHC

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.02.027

7 January 2021

Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.02.027

7 January 2021

Transarterial chemoembolization as a bridge to liver transplantation for hepatocellular carcinoma: an evidence-based analysis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.02.027

7 January 2021

Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: an intention-to-treat analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.02.027

7 January 2021

Transarterial chemoinfusion for hepatocellular carcinoma as downstaging therapy and a bridge toward liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.02.027

7 January 2021

Liver transplantation for small hepatocellular carcinoma in cirrhosis: analysis of our experience

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.02.027

7 January 2021

Liver transplantation for hepatocellular carcinoma: Are the Milan criteria still valid?

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.02.027

7 January 2021

Hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.02.027

7 January 2021

Applying expanded criteria to liver transplantation for hepatocellular carcinoma: too much too soon, or is now the time?

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.02.027

7 January 2021

Accuracy of staging as a predictor for recurrence after liver transplantation for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.02.027

7 January 2021

Expanded criteria for liver transplantation in patients with hepatocellular carcinoma: a report from the International Registry of Hepatic Tumors in Liver Transplantation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.02.027

7 January 2021

Liver transplantation for hepatocellular carcinoma: comparison of the proposed UCSF criteria with the Milan criteria and the Pittsburgh modified TNM criteria

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.02.027

7 January 2021

Liver transplantation criteria for hepatocellular carcinoma should be expanded: a 22-year experience with 467 patients at UCLA

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.02.027

7 January 2021

Liver transplantation for hepatocellular carcinoma: validation of the UCSF-expanded criteria based on preoperative imaging

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.02.027

7 January 2021

Liver splitting and living donor techniques

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.02.027

7 January 2021

Improvement in survival associated with adult-to-adult living donor liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.02.027

7 January 2021

Expansion of selection criteria for patients with hepatocellular carcinoma in living donor liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.02.027

7 January 2021

Identifiers

10.1016/J.TRANSPROCEED.2010.02.027

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38485998&oldid=1532040806"